Acknowledgement
We gratefully acknowledge the support of Dr. Douglas Rizzo, Senior Scientific Director from CIBMTR who introduced us to the eDBtC platform. We thank the nonprofit Children’s Miracle Network for their 2018 and 2020 grants in support of FPBCC.
.References
  1. Bhatia S, Sather H, Heerema N, Trigg M, Gaynon P and Robinson L. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood. 2002;100(6):1957-1964.
  2. Kadan-Lottick N, Ness K, Bhatia S, and Gurney J. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA. 2003;290:2008-2014.
  3. Goggins W, Lo FK. Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988-2008. Cancer Causes Control.2012;23(5):737-43.
  4. Kritane K, Lee S. Racial and ethnic disparities in hematologic malignancies. Blood 2017;130:1699-1705.
  5. Aplenc R, Alonzo TA, Gerbingf RB, Smith FO, Meshinchi S, Ross JA, et al. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children’s Oncology Group. Blood. 2006;108:74-80.
  6. Bhatia S. Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr Blood Cancer 2011.2011;56:994-1002.
  7. Baker S, Davies S, Majhail N, Hassebroek A, Klein J, Ballen K, et al. Race and Socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009;15:1543-1554.
  8. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: Working Definitions. Biol Blood Marrow Transplant 2009; 15:1628-33.
  9. Przepiorka D, Weisdorf D, Martin R, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus conference on Acute GVHD Grading. Bone Marrow Transplant.1995;15:825-8.
  10. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med.1980;69:204-17.
  11. Majhail NS, Nayyar S, Santibanez B, Murphy EA, and Denzen EM. Racial disparities in hematopoietic cell transplantation in the United States. Bone Marrow Transplant 2012;47(11):doi.10.1038/bmt.2011.214.
  12. Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, et al. Access to hematopoietic stem cell transplantation: effect of race and sex. Cancer. 2010; 116:3469-3476.
  13. Mitchell JM, Meehan KR, Kong J, Schulman KA. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J Clin Oncol. 1997;15:2644-2651.
  14. Hwang JP, Lam TP, Cohen DS, Donato ML, Geraci JM. Hematopoietic stem cell transplantation among patients with leukemia of all ages in Texas. Cancer. 2004;101:2230-2238.
  15. Oh H, Loberiza F, Zhang M-J, Ringden O, Akiyama H, Asai T, et al. Comparison of graft-versus-host disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 2005;105:1408-1416.
  16. Symons H, Zahurak M, Cao A, Chen A, Cooke K, Gamper C, et al. Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults. Blood Adv 2020; 4:3913-3925.
  17. Fuchs E, O’Donnell P, Eapen M, Logan B, Antin J, Dawson P, et al. Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: CTN 1101 trial. Blood 2021;137:420-428.
Figure Legends:Figure 1 Overall Survival by Race Figure 2 Overall Survival by HLA-Match, A – White HCT Recipients, B- Black HCT recipients
Data Access:
The data that support the findings of this study are available from the corresponding author upon a reasonable request.